This article provides a comprehensive overview of Febantel CAS 58306-30-2, an anthelmintic drug widely used in veterinary medicine. It delves into the pharmacology and safety aspects of Febantel, exploring its mechanism of action, efficacy in treating various helminth infections, pharmacokinetics, side effects, and overall safety profile. The article aims to provide healthcare professionals and researchers with a detailed understanding of Febantel's properties and its role in combating helminth infections.
Febantel, also known as 2-(4-chlorophenyl)-4-(methylsulfinyl)-1-(p-tolyl)-1H-pyrazole-5-carboxamide, is an anthelmintic drug that has gained significant attention in veterinary medicine. It is primarily used to treat a wide range of helminth infections in animals, including dogs, cats, and livestock. This article aims to explore the pharmacology and safety profile of Febantel, highlighting its mechanism of action, efficacy, pharmacokinetics, side effects, and overall safety.
Febantel belongs to the benzimidazole class of anthelmintics, which are known for their efficacy against nematodes. The drug works by inhibiting the synthesis of microtubules in the nematode's gut, leading to paralysis and subsequent expulsion of the worms. This mechanism of action makes Febantel effective against a variety of nematode species, including Ascaris, Toxocara, and Trichuris.
The pharmacokinetics of Febantel in animals have been extensively studied. It is rapidly absorbed from the gastrointestinal tract and distributed throughout the body. The drug is metabolized in the liver and excreted primarily in the urine. The pharmacokinetic profile of Febantel varies among different animal species, with dogs and cats showing rapid absorption and elimination.
Febantel has been proven to be highly effective in treating various helminth infections in animals. Clinical trials have demonstrated its efficacy against nematodes, cestodes, and acanthocephalans. The drug is particularly effective against Ascaris, which is one of the most common nematode infections in dogs and cats.
In addition to its efficacy against nematodes, Febantel has also shown promise in treating cestode infections, such as tapeworms. The drug has been used successfully in treating Taenia species, which are known to cause significant health issues in animals.
The safety profile of Febantel is generally considered to be good, with minimal side effects reported in clinical use. The drug is well-tolerated by most animals, and adverse reactions are rare. However, as with any medication, there may be individual variations in response.
The most common side effects reported with Febantel include vomiting, diarrhea, and anorexia. These side effects are usually mild and transient, resolving on their own or with supportive treatment. In rare cases, more serious adverse reactions may occur, such as allergic reactions or liver toxicity. It is important for veterinary professionals to monitor animals closely after administering Febantel to detect any potential adverse effects early.
Febantel is contraindicated in animals with known hypersensitivity to the drug or other benzimidazole compounds. It should also be used with caution in animals with pre-existing liver or kidney disease, as these conditions may affect the drug's metabolism and excretion.
Veterinary professionals should also be aware of potential drug interactions with Febantel. For example, the drug may interact with other anthelmintics, antacids, and certain antibiotics. It is important to consult with a veterinarian before administering Febantel to an animal that is already receiving other medications.
In conclusion, Febantel CAS 58306-30-2 is a valuable anthelmintic drug with a well-established pharmacology and safety profile. Its efficacy against a wide range of helminth infections, coupled with its generally good safety profile, makes it a preferred choice for veterinary use. However, as with any medication, it is important for healthcare professionals to be aware of the drug's mechanism of action, efficacy, pharmacokinetics, side effects, and precautions to ensure optimal patient care.
Keywords: Febantel, anthelmintic, pharmacology, safety, efficacy, veterinary medicine
English (United States) 
English (Australia) 
Spanish 
Portuguese